Skip to main content
. 2017 May 22;6(5):e339. doi: 10.1038/oncsis.2017.31

Figure 7.

Figure 7

Sp1 induces CYP17A1 overexpression by inhibiting DNMT3a-mediated DNA methylation, thus resulting in an increase in DHEA biosynthesis and glioma resistance to TMZ.